Tag: Ceritinib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Ceritinib

U.S. FDA Expands Approval of Pfizer's LORBRENA® as First-Line Treatment for ALK-Positive ...

Added to Collection on: 2021-03-04 14:44:28

Tags for this article:

Chemical compounds
Organic compounds
Piperidines
Breakthrough therapy
Protein kinase inhibitors
Tyrosine kinase receptors
Lung cancer
Lorlatinib
Ceritinib
ALK inhibitor
Anaplastic lymphoma kinase
ROS1
XALKORI
Pfizer Inc.
Alectinib
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Pfizer's Lorbrena breaks into front-line ALK lung cancer, jostling with Novartis, Roche and Takeda

Added to Collection on: 2021-03-04 15:45:00

Tags for this article:

Chemical compounds
Piperidines
Organic compounds
Chemistry
Protein kinase inhibitors
Breakthrough therapy
Orphan drugs
Lung cancer
Ceritinib
Crizotinib
ALK inhibitor
Anaplastic lymphoma kinase
Pfizer
XALKORI
Lorbrena
PFIZER'S

Click the tags to see associated articles and topics

View Article Details
Roche receives FDA approval for VENTANA ALK (D5F3) CDx Assay to identify lung cancer ...

Added to Collection on: 2021-03-09 06:00:00

Tags for this article:

Chemical compounds
Organic compounds
Piperidines
Chemistry
Lung cancer
Breakthrough therapy
Protein kinase inhibitors
Tyrosine kinase receptors
Anaplastic lymphoma kinase
Ceritinib
Crizotinib
Alectinib
Roche Group

Click the tags to see associated articles and topics

View Article Details
FDA Approves CDx for Lorlatinib in ALK-Positive Non–Small Cell Lung Cancer

Added to Collection on: 2021-03-09 19:07:21

Tags for this article:

Chemical compounds
Organic compounds
Chemistry
Piperidines
Breakthrough therapy
Protein kinase inhibitors
Lung cancer
Orphan drugs
ALK inhibitor
Ceritinib
Anaplastic lymphoma kinase
Lorlatinib
Roche

Click the tags to see associated articles and topics

View Article Details
Impact of covid-19 on Ceritinib Sales market Report to 2027 - Industry Demand Analysis and ...

Added to Collection on: 2021-07-26 07:07:30

Tags for this article:

Health sciences
Health care
Health
Breakthrough therapy
Ceritinib
Marketing strategy
Novartis
Market share
Pharmaceutical industry in China
Pricing
Pharmaceutical industry in India
Mergers and acquisitions

Click the tags to see associated articles and topics

View Article Details
Pfizer Gets EC OK for Lorviqua as First-Line Treatment for ALK-Positive Advanced Lung ...

Added to Collection on: 2022-01-28 18:08:35

Tags for this article:

Chemical compounds
Organic compounds
Aromatic compounds
Breakthrough therapy
Piperidines
Lung cancer
Tyrosine kinase receptors
Anaplastic lymphoma kinase
Ceritinib
Crizotinib
ALK inhibitor
Alectinib

Click the tags to see associated articles and topics

View Article Details
European Commission Approves LORVIQUA® (lorlatinib) as a First-Line Treatment for ALK ...

Added to Collection on: 2022-01-30 10:05:42

Tags for this article:

Chemical compounds
Organic compounds
Aromatic compounds
Breakthrough therapy
Tyrosine kinase receptors
Lung cancer
Piperidines
Orphan drugs
ALK inhibitor
Anaplastic lymphoma kinase
Ceritinib
Lorlatinib
XALKORI
I Pfizer Inc.

Click the tags to see associated articles and topics

View Article Details
Pfizer (PFE) Lorviqua Gets EU Nod for First-Line Lung Cancer - Entrepreneur

Added to Collection on: 2022-01-31 18:16:09

Tags for this article:

Chemical compounds
Organic compounds
Chemistry
Breakthrough therapy
Piperidines
Lung cancer
Tyrosine kinase receptors
Ceritinib
ALK inhibitor
Anaplastic lymphoma kinase
Crizotinib
Alectinib

Click the tags to see associated articles and topics

View Article Details
Repurposed Drug Can Target Cancer Cells' Shield Against Immune System

Added to Collection on: 2022-08-25 08:52:36

Tags for this article:

Enzymes
Medicine
Immunology
Cancer treatments
ENTPD1
Cancer immunotherapy
Kinase
Ectonucleotidase
Ceritinib
Cancer
Protein kinase
Immune system
CD39

Click the tags to see associated articles and topics

View Article Details
A novel IGR-ALK fusion in a patient with lung adenocarcinoma | OTT - Dove Medical Press

Added to Collection on: 2024-03-26 16:24:41

Tags for this article:

Lung cancer
CYP3A4 inhibitors
Pyrazoles
Piperidines
Orphan drugs
ALK inhibitor
Anaplastic lymphoma kinase
Crizotinib
Ceritinib
Adenocarcinoma of the lung
Non-small-cell lung cancer
Alectinib

Click the tags to see associated articles and topics

View Article Details